Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to treat solid tumor cancers and chemotherapy-induced peripheral neuropathy (CIPN) ...

Submit your research for the call for abstracts due March 31, 2026. Join us at the APHA Annual Meeting and Expo.

CARY, N.C. — January 7, 2026 — INDA, the Association of the Nonwoven Fabrics Industry, in partnership with AFS, the American ...

The Seismological Society of America (SSA) will be holding its annual meeting on 14-18 April 2026 at the Pasadena Convention Center in Pasadena, California. The meeting attracts more than 800 ...

The chief executive of Waste Management runs a company worth tens of billions of dollars, yet he has spent nights riding ...

New Year’s resolutions usually fail for the same reason every year: enthusiasm shows up, structure doesn’t. Big goals sound ...

This weekend, head along to Australia’s wildest horsepower party, dance in the NFSA courtyard during Hot Summer Nights, and ...

Summernats roars into town, Bluey hits the stage, and the Old Bus Depot Markets are back. Your first full week of 2026 is ...

DEM BioPharma, Inc. (DEM Bio), a biopharmaceutical company dedicated to discovering novel targets for solid tumors and developing innovative, first-in-class, cancer medicines, today announced that ...

Iksuda Therapeutics (Iksuda), the developer of class leading, antibody drug conjugates (ADCs), today announces the presentation of early analyses of activity in patients with oesophageal cancer during ...

Quest Diagnostics , a leading provider of diagnostic information services, today announced that data will be shared on circulating tumor DNA (ctDNA) minimal residual disease (MRD) testing during two ...

8:30 a.m. The December Jobs Report will be released. Economists forecast that nonfarm payrolls will rise by about 55,000 jobs ...